QuidelOrtho Corporation QDEL Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| China | $63.5M-30.8% | $91.7M+8.4% | $84.6M+1.4% | $83.4M+11.2% | $75M-13.7% | |
| EMEA | $92.5M-0.2% | $92.7M+1.0% | $91.8M+5.2% | $87.3M-1.8% | $88.9M+3.5% | |
| JPAC | $70M— | —— | —— | —— | $68.1M-2.5% | |
| Latin America | $64.9M— | —— | —— | —— | $54.1M-2.9% | |
| North America | $328.9M-15.7% | $390.1M+2.3% | $381.4M+22.8% | $310.7M-23.6% | $406.7M+1.8% | |
| Segment Information, Other Income (Expense) by Business | ||||||
| China | $200K+100% | $100K+200% | -$100K-109% | $1.1M— | $0— | |
| EMEA | -$800K-14.3% | -$700K+22.2% | -$900K-12.5% | -$800K+50.0% | -$1.6M-77.8% | |
| JPAC | $700K— | —— | —— | —— | $0-100% | |
| Latin America | $100K— | —— | —— | —— | $200K-46.7% | |
| North America | -$200K0.0% | -$200K-100% | -$100K— | $0— | $0-100% | |
| Segment Adjusted EBITDA by Business | ||||||
| China | $20.5M-37.9% | $33M-10.3% | $36.8M-12.6% | $42.1M+43.7% | $29.3M-8.2% | |
| EMEA | $20.1M-14.1% | $23.4M-4.1% | $24.4M+33.3% | $18.3M+10.9% | $16.5M+66.7% | |
| JPAC | $16.5M— | —— | —— | —— | $17.6M+0.7% | |
| Latin America | $15.8M— | —— | —— | —— | $12M-24.5% | |
| North America | $169.4M-16.2% | $202.2M-4.1% | $210.8M+32.0% | $159.7M-31.8% | $234.3M+5.6% | |
| Cost of sales, excluding amortization of intangibles by Business | ||||||
| China | $32M-30.7% | $46.2M+26.9% | $36.4M+18.2% | $30.8M-9.9% | $34.2M-18.4% | |
| EMEA | $44.6M+2.5% | $43.5M+5.6% | $41.2M-6.2% | $43.9M-7.2% | $47.3M-1.7% | |
| JPAC | $41.5M— | —— | —— | —— | $37.9M-1.6% | |
| Latin America | $36.7M— | —— | —— | —— | $32.1M+9.6% | |
| North America | $114.5M-20.5% | $144.1M+11.7% | $129M+16.6% | $110.6M-13.9% | $128.4M-2.9% | |
| Selling, marketing and administrative by Business | ||||||
| China | $10.5M-11.8% | $11.9M+12.3% | $10.6M-1.9% | $10.8M+1.9% | $10.6M-10.9% | |
| EMEA | $26.6M+9.5% | $24.3M-1.2% | $24.6M+4.2% | $23.6M+3.1% | $22.9M-12.6% | |
| JPAC | $12.4M— | —— | —— | —— | $12.2M-10.6% | |
| Latin America | $12M— | —— | —— | —— | $9.8M-6.7% | |
| North America | $44.4M+2.8% | $43.2M+5.1% | $41.1M+2.8% | $40M-8.3% | $43.6M-3.3% | |
| R&D by Business | ||||||
| China | $700K0.0% | $700K0.0% | $700K-12.5% | $800K-11.1% | $900K-25.0% | |
| EMEA | $400K-50.0% | $800K+14.3% | $700K0.0% | $700K+16.7% | $600K-25.0% | |
| JPAC | $300K— | —— | —— | —— | $400K+6.7% | |
| Latin America | $500K— | —— | —— | —— | $400K0.0% | |
| North America | $400K0.0% | $400K0.0% | $400K0.0% | $400K0.0% | $400K0.0% | |
| Percentage of risk concentration by Product | ||||||
| Respiratory | 11%+10.0pp | 1%-15.0pp | 16%+8.0pp | 8%-9.0pp | 17%+16.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does QuidelOrtho Corporation break its business down?
- QuidelOrtho Corporation (QDEL) reports total revenues by business across 5 parts — China, EMEA, JPAC, Latin America and North America. Each is extracted from the segment footnotes and tracked over time.
- Where does QuidelOrtho Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in QuidelOrtho Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
